Race to Cure Sarcoma Baltimore is GOING VIRTUAL
The highest priority of the Sarcoma Foundation of America is the health and safety of our community. With that in mind we have decided to make our Inaugural Race to Cure Sarcoma Baltimore a VIRTUAL event!
What does this mean?
Run, walk, bike, roll or hop in your neighborhood or on your treadmill any distance you would like on July 25, 2020, this virtual event will be a part of our National Virtual RTCS event in honor of Sarcoma Awareness Month. Registered participants will receive a race packet that consists of a National Virtual RTCS shirt, wristband and race bib.
Wear your National Virtual RTCS shirt, bib and wristband and share on social media using the hashtag #NationalVirtualRTCSBaltimore! We will have a full program on July 25 that highlights participants and sponsors, a kickoff speaker and other ways for you to engage as you support sarcoma research.
Wondering how you can help now?
If you're already registered, then keep fundraising, and invite your friends to join and register as virtual walker/runner! They can be anywhere in the county and support you and sarcoma research!
We appreciate your understanding & patience during this difficult time. Thank you for your continued support of the Race to Cure Sarcoma Baltimore event and the SFA.
5k course will be a timed event. You may walk or run!
If you selected this course, you will not be timed!
When you choose to take part in the Race to Cure Sarcoma Baltimore, you are choosing to join hundreds of others who want to make a difference for sarcoma patients and their families. Join us and the sarcoma community and be a part of the premier run/walk series in the United States focused on raising awareness and research funds for sarcoma.
Funds raised through RTCS Baltimore drives innovative sarcoma research nationally, through the Sarcoma Foundation of America, and locally through the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.
Fundraising through this event drives innovative research through the Sarcoma Foundation of America and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.